EUVIMEDEUVIMED entdecken
Crossref

Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

Yitong He, Tao Liu, Haiyan Song

Liver International · 2026-12 · 46 (12)

DOI: 10.1111/liv.70946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 20.11.2026. Verfasst von Yitong He und 2 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

He, Y., Liu, T., & Song, H. (2026). Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab. Liver International, 46(12). https://doi.org/10.1111/liv.70946

Vancouver

He Y, Liu T, Song H. Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab. Liver International. 2026;46(12). doi:10.1111/liv.70946

BibTeX
@article{He2026,
  author = {He, Yitong and Liu, Tao and Song, Haiyan},
  title = {Cardiovascular Event Windows in Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {12},
  doi = {10.1111/liv.70946}
}
Kostenlos starten →